UBE2G1, ubiquitin-conjugating enzyme E2 G1, is a pivotal component of the ubiquitin-proteasome pathway, a sophisticated system responsible for the degradation of intracellular proteins, thus maintaining cellular homeostasis. Within this intricate pathway, UBE2G1 serves a key function as an intermediary enzyme. It takes on the responsibility of accepting a ubiquitin moiety from an activating enzyme (often denoted as E1) and subsequently shuttles this ubiquitin to a target protein. This transfer is facilitated with the collaboration of a ligase enzyme, usually referred to as E3. The sequential tagging of proteins with chains of ubiquitin serves as a marker, designating those proteins for elimination by the proteasome. This tagging and degradation process is pivotal for various cellular processes including cell cycle progression, transcriptional regulation, and the rapid removal of misfolded proteins.
Within this context, the chemical class known as UBE2G1 Activators emerges as a collection of molecules specifically designed to augment the activity of the UBE2G1 enzyme. Their operational mechanisms can be multifaceted. Some of these activators may interact directly with the UBE2G1 enzyme, binding in such a manner that induces a structural shift in the enzyme. This conformational alteration can make the enzyme more adept at receiving and transferring ubiquitin. Conversely, other activators operate indirectly. They might thwart the function of molecules that typically repress UBE2G1 or they could stabilize the enzyme, extending its operational lifespan within the cell. An additional tier of these activators might function at the genetic level, either enhancing the transcription of the UBE2G1 gene or promoting its translation, which subsequently amplifies the production and presence of the enzyme in the cellular milieu.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, potentially influencing UBE2G1 | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that might affect UBE2G1 levels | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Sirtuin activator that might influence UBE2G1 transcription | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist affecting gene transcription | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Influences differentiation and might affect UBE2G1 levels | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
HDAC inhibitor, epigenetic regulation possibly affecting UBE2G1 | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, could potentially influence UBE2G1 | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor possibly affecting UBE2G1 | ||||||